Biology and therapeutic targeting of vascular endothelial growth factor A

L Pérez-Gutiérrez, N Ferrara - Nature Reviews Molecular Cell Biology, 2023 - nature.com
The formation of new blood vessels, called angiogenesis, is an essential pathophysiological
process in which several families of regulators have been implicated. Among these, vascular …

Preeclampsia: pathophysiology, challenges, and perspectives

S Rana, E Lemoine, JP Granger… - Circulation …, 2019 - Am Heart Assoc
Hypertensive disorders of pregnancy—chronic hypertension, gestational hypertension, and
preeclampsia—are uniquely challenging as the pathology and its therapeutic management …

Pre-eclampsia: pathogenesis, novel diagnostics and therapies

EA Phipps, R Thadhani, T Benzing… - Nature Reviews …, 2019 - nature.com
Pre-eclampsia is a complication of pregnancy that is associated with substantial maternal
and fetal morbidity and mortality. The disease presents with new-onset hypertension and …

Placental growth factor and pre-eclampsia

K Chau, A Hennessy, A Makris - Journal of human hypertension, 2017 - nature.com
Placental growth factor (PlGF) is an increasingly important molecule in the prediction,
diagnosis and treatment of pre-eclampsia. It has pro-angiogenic effects on the feto-placental …

[HTML][HTML] Preeclampsia: A review of the pathogenesis and possible management strategies based on its pathophysiological derangements

AAF El-Sayed - Taiwanese Journal of Obstetrics and Gynecology, 2017 - Elsevier
This review is divided into three parts. The first part briefly describes the pathogenesis of
preeclampsia. This is followed by reviewing previously reported management strategies of …

RNAi modulation of placental sFLT1 for the treatment of preeclampsia

AA Turanov, A Lo, MR Hassler, A Makris… - Nature …, 2018 - nature.com
Preeclampsia is a placentally induced hypertensive disorder of pregnancy that is associated
with substantial morbidity and mortality to mothers and fetuses. Clinical manifestations of …

Circulating angiogenic factor levels in hypertensive disorders of pregnancy

R Thadhani, E Lemoine, S Rana… - NEJM …, 2022 - evidence.nejm.org
Background Among women with hypertensive disorders of pregnancy, biomarkers may
stratify risk for develo** preeclampsia with severe features (sPE). Methods Across 18 US …

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia: Compiled by the …

LC Poon, LA Magee, S Verlohren… - … of Gynecology & …, 2021 - Wiley Online Library
Pre-eclampsia is a multisystem disorder that typically affects 2%–5% of pregnant women
and is one of the leading causes of maternal and perinatal morbidity and mortality …

Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia

S Tong, J Tu'uhevaha, R Hastie, F Brownfoot… - American journal of …, 2022 - Elsevier
There has been increasing research momentum to identify new therapeutic agents for the
prevention or treatment of preeclampsia, drugs that can affect the underlying disease …

Targeting angiogenesis and lymphangiogenesis in kidney disease

K Tanabe, J Wada, Y Sato - Nature Reviews Nephrology, 2020 - nature.com
The kidney is permeated by a highly complex vascular system with glomerular and
peritubular capillary networks that are essential for maintaining the normal functions of …